Sanara MedTech Inc. (SMTI): Price and Financial Metrics
SMTI Price/Volume Stats
| Current price | $32.44 | 52-week high | $46.40 |
| Prev. close | $31.01 | 52-week low | $26.06 |
| Day low | $31.00 | Volume | 25,200 |
| Day high | $33.83 | Avg. volume | 13,231 |
| 50-day MA | $35.16 | Dividend yield | N/A |
| 200-day MA | $35.45 | Market Cap | 279.73M |
SMTI Stock Price Chart Interactive Chart >
Sanara MedTech Inc. (SMTI) Company Bio
Sanara MedTech, Inc.engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. It offers CellerateRX Surgical Activated Collagen Adjuvant and HemaQuell Resorbable Bone Hemostat. The company was founded in 1982 and is headquartered in Fort Worth, TX.
Latest SMTI News From Around the Web
Below are the latest news stories about SANARA MEDTECH INC that investors may wish to consider to help them evaluate SMTI as an investment opportunity.
Sanara MedTech Inc.'s (NASDAQ:SMTI) top owners are retail investors with 32% stake, while 31% is held by insidersKey Insights The considerable ownership by retail investors in Sanara MedTech indicates that they collectively have a... |
Sanara MedTech Inc. Announces the Publication of a 5,335 Patient Study Demonstrating a Significant Reduction in Surgical Site Infections When Activated Collagen (CellerateRX® Surgical Powder) Was Used to Promote Wound HealingFORT WORTH, TX, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, announced today that the Journal of Surgery has published a retrospective study on CellerateRX® Surgica |
Sanara MedTech Inc. Reports Record Sales in Q3 2023 with Narrowed Net Loss and Positive ...Strategic Acquisitions and Product Launches Propel Growth Amidst Operational Challenges |
Sanara MedTech Inc. Announces Third Quarter 2023 ResultsFORT WORTH, TX, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, announced today its strategic, operational and financial results for the quarter ended September 30, 20 |
Sanara MedTech Inc. Announces Third Quarter Earnings Release and Conference Call DatesFORT WORTH, TX, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, announced today details for the release of its results for the quarter ended September 30, 2023. Sanara |
SMTI Price Returns
| 1-mo | -4.39% |
| 3-mo | -7.23% |
| 6-mo | 17.07% |
| 1-year | -14.18% |
| 3-year | 18.83% |
| 5-year | 548.80% |
| YTD | -21.07% |
| 2023 | -9.67% |
| 2022 | 53.98% |
| 2021 | -40.78% |
| 2020 | 209.94% |
| 2019 | 392.35% |
Loading social stream, please wait...